Omega 3-6-7-9: Do You Need All of Them and What the Science Says
Multi-omega supplements promising "complete omega coverage" with omega-3, 6, 7, and 9 in a single capsule are everywhere. The marketing suggests you need all four families for optimal health. The reality is more nuanced: one of these is genuinely important for most people, two you probably already get plenty of, and one is a niche ingredient with limited evidence.
This guide breaks down each omega family honestly — what the research supports, what it does not, and where your money is better spent.
TL;DR
- Omega-3 (EPA + DHA) is the only omega most people should actively seek to increase through diet or supplements
- Omega-6 is already overconsumed in modern Western diets; supplementation is rarely needed
- Omega-7 (palmitoleic acid) has emerging but limited evidence, mainly for metabolic markers
- Omega-9 (oleic acid) is a non-essential fatty acid abundantly found in olive oil; supplementation is unnecessary
- Multi-omega combo products often underdose EPA/DHA to make room for omegas you do not need
- A quality standalone fish oil or algae omega-3 supplement is a better choice than a "3-6-7-9" combo
Omega-3: The One That Actually Matters
Omega-3 fatty acids are polyunsaturated fats that your body cannot synthesize — they must come from diet. The three main types are:
ALA (alpha-linolenic acid) — Found in flaxseed, chia, and walnuts. This is the plant-based omega-3, but conversion to the active forms (EPA and DHA) is extremely inefficient: only 5-10% of ALA converts to EPA, and less than 1% to DHA (Burdge & Calder, 2005).
EPA (eicosapentaenoic acid) — Found primarily in fatty fish and algae. Anti-inflammatory, supports cardiovascular health, and has evidence for mood support (Grosso et al., 2014).
DHA (docosahexaenoic acid) — Found in fatty fish and algae. Critical for brain structure (makes up 40% of polyunsaturated fats in the brain), retinal function, and fetal neurodevelopment (Innis, 2007).
What the Evidence Supports
Cardiovascular health: The VITAL trial (2019) showed that 1 g/day of omega-3 (840 mg EPA+DHA) reduced major cardiovascular events by 28% in people with low fish intake (Manson et al., 2019). The REDUCE-IT trial showed high-dose EPA (4 g icosapent ethyl) reduced cardiovascular events by 25% in statin-treated patients with elevated triglycerides (Bhatt et al., 2019).
Triglyceride reduction: At doses of 2-4 g/day EPA+DHA, triglycerides decrease 15-30% (EFSA, 2010). This is a well-established effect.
Brain and eye health: DHA is structurally essential for brain and retinal tissue. Evidence for preventing cognitive decline in healthy adults is mixed, but adequate DHA intake during pregnancy and infancy is critical for neurodevelopment (Innis, 2007).
Inflammation: EPA and DHA are precursors to resolvins and protectins — specialized pro-resolving mediators that actively resolve inflammation rather than just suppressing it (Serhan, 2014).
Recommended Intake
| Population | EPA + DHA Target | Notes |
|---|---|---|
| General adult health | 250-500 mg/day | EFSA recommendation (EFSA, 2010) |
| Cardiovascular risk | 1000 mg/day | Based on VITAL trial |
| High triglycerides | 2000-4000 mg/day | Medical supervision recommended |
| Pregnancy/lactation | 200 mg DHA minimum | EFSA recommendation |
| Depression (adjunct) | 1000-2000 mg EPA | Research-based, not formal guideline |
Omega-6: You Already Get Too Much
Omega-6 fatty acids, primarily linoleic acid (LA), are also essential — your body cannot make them. The main dietary source is vegetable oils: sunflower, corn, soybean, and safflower oil.
Here is the problem: the modern Western diet is already extremely high in omega-6. The estimated omega-6 to omega-3 ratio in typical Western diets is 15-20:1, while the ratio associated with lower chronic disease risk is closer to 4:1 or lower (Simopoulos, 2002).
Why Supplementing Omega-6 Is Usually Wrong
- You almost certainly get more than enough LA from cooking oils, processed foods, nuts, and seeds
- Excess omega-6 relative to omega-3 promotes an inflammatory milieu by competing for the same enzymes (delta-6 desaturase) that convert both families
- The goal should be to increase omega-3 and moderate omega-6, not add more omega-6 via supplements
The Exception: GLA
Gamma-linolenic acid (GLA), found in evening primrose oil, borage oil, and black currant seed oil, is an omega-6 with anti-inflammatory properties. It has some evidence for atopic dermatitis, PMS symptoms, and rheumatoid arthritis (Zurier et al., 1996). This is a targeted supplement for specific conditions, not a general recommendation.
Omega-7: Emerging but Unproven
Omega-7 fatty acids, primarily palmitoleic acid, are found in macadamia nuts and sea buckthorn oil. They are not essential — your body can synthesize them.
Current Evidence
- Metabolic markers: A small RCT showed that purified palmitoleic acid (220 mg/day) reduced CRP by 44% and lowered triglycerides in overweight subjects (Bernstein et al., 2014). Promising, but this is a single small study
- Skin and mucosal health: Sea buckthorn oil (which contains omega-7 along with other bioactives) has been studied for vaginal dryness and dry eye, with modest positive results (Larmo et al., 2014)
- Cardiovascular: Very limited data; some observational studies show associations between circulating palmitoleic acid and lower cardiovascular risk, but this does not prove supplementation helps
The Honest Assessment
Omega-7 is interesting but preliminary. If you eat macadamia nuts or use sea buckthorn products, you already get some. Dedicated omega-7 supplements are a gamble on future evidence.
Omega-9: Completely Unnecessary as a Supplement
Omega-9 fatty acids, primarily oleic acid, are monounsaturated and non-essential — your body makes them. They are the main fat in olive oil, avocados, and almonds.
The health benefits of oleic acid are well-established in the context of the Mediterranean diet (Estruch et al., 2013). But these benefits come from eating olive oil and whole foods, not from taking oleic acid in capsule form.
Why Omega-9 Supplements Make No Sense
1. Your body synthesizes oleic acid — it is literally non-essential
2. A tablespoon of olive oil provides about 10 g of oleic acid — more than any supplement capsule
3. No clinical trials have shown benefits of supplemental omega-9 beyond dietary sources
4. In combo products, omega-9 takes up capsule space that could go to EPA/DHA
The Multi-Omega Trap
Here is the core problem with "omega 3-6-7-9" combo supplements:
They underdose the ingredient that matters (omega-3) to make room for ingredients you do not need (omega-6, 9) or that lack evidence (omega-7).
A typical combo capsule might contain:
- 180 mg EPA + 120 mg DHA (only 300 mg combined — well below the 500-1000 mg target)
- 200 mg linoleic acid (omega-6 you already overconsume)
- 50 mg palmitoleic acid (omega-7 with limited evidence)
- 200 mg oleic acid (omega-9 your body makes)
You would need 2-3 capsules of a combo product just to match the EPA+DHA in a single capsule of a quality fish oil concentrate.
What to Buy Instead
| Product Type | Typical EPA+DHA per Capsule | Best For |
|---|---|---|
| Omega 3-6-7-9 combo | 200-400 mg | Marketing, not health |
| Standard fish oil (1000 mg) | 300-360 mg | Budget option |
| Concentrated fish oil | 500-800 mg | Best value for cardiovascular |
| High-EPA concentrate | 600-900 mg EPA | Inflammation, mood |
| Algae omega-3 (vegan) | 250-500 mg DHA | Vegetarians, vegans |
Best Food Sources for Omega-3
| Food | EPA+DHA (mg per 100g) | Notes |
|---|---|---|
| Atlantic mackerel | 2500-3000 | Best value per euro |
| Salmon (wild) | 1800-2500 | Most popular choice |
| Sardines | 1400-2000 | Sustainable, low mercury |
| Herring | 1700-2400 | Traditional Baltic fish |
| Trout | 800-1200 | Freshwater option |
| Anchovies | 1400-2000 | Great in cooking |
In Estonia, Baltic herring (räim) and sprats (kilu) are affordable local omega-3 sources. Two servings of fatty fish per week generally provide the recommended 250-500 mg/day of EPA+DHA.
Common Mistakes
1. Buying "3-6-7-9" combos instead of quality omega-3 — you pay more and get less of what matters
2. Relying on ALA (flax oil) as your omega-3 — conversion to EPA/DHA is too low (Burdge & Calder, 2005). If you do not eat fish, take an algae-based EPA+DHA supplement
3. Ignoring dosage per capsule — always check EPA+DHA mg, not total "fish oil" mg. A 1000 mg fish oil capsule may contain only 300 mg EPA+DHA
4. Storing fish oil improperly — oxidized omega-3 smells rancid and may be harmful. Store in a cool, dark place; refrigerate after opening
5. Taking omega-3 with expectations of overnight results — anti-inflammatory and cardiovascular benefits develop over weeks to months of consistent use
FAQ
Do I need to take omega-6 and omega-9 supplements?
Almost certainly not. Omega-6 is abundant in modern diets (cooking oils, processed foods), and omega-9 is non-essential (your body makes it). Focus on omega-3, specifically EPA and DHA.
Is fish oil or krill oil better?
Fish oil provides higher absolute amounts of EPA+DHA per capsule and is more cost-effective. Krill oil contains phospholipid-bound omega-3 (potentially better absorbed per mg) and astaxanthin, but at much lower total EPA+DHA per capsule and higher cost. For most people, concentrated fish oil is the better choice.
Can vegans get enough omega-3?
Yes, with algae-based EPA+DHA supplements. Algae is where fish get their omega-3 in the first place. Flaxseed oil (ALA) alone is insufficient because conversion to EPA/DHA is very poor.
How much fish oil is too much?
EFSA considers up to 5 g/day of EPA+DHA as safe for adults. Above 3 g/day, there may be a slight increase in bleeding time (clinically irrelevant for most people). If you take blood thinners, discuss with your doctor.
Should I take omega-3 with food?
Yes. Fat-soluble supplements absorb significantly better when taken with a meal containing fat. One study showed 3x better absorption with a high-fat meal versus fasting (Lawson & Hughes, 1988).
Estonia-Specific Notes
Estonia has excellent access to omega-3-rich fish. Baltic herring (räim) is among the most affordable omega-3 sources in Europe at €3-5/kg. Sprats (kilu), smoked mackerel, and salmon are widely available in supermarkets (Selver, Rimi, Coop). For supplements, fish oil capsules are available in pharmacies (€8-20 depending on concentration) and online. Estonian dietary surveys suggest that fish consumption averages 15-20 kg/year per capita — below the 26 kg EU average but above many landlocked countries.
References
- Bernstein, A. M., Roizen, M. F. & Martinez, L. (2014). Purified palmitoleic acid for the reduction of high-sensitivity C-reactive protein and serum lipids. Journal of Clinical Lipidology, 8(6), 612-617.
- Bhatt, D. L., Steg, P. G., Miller, M., et al. (2019). Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. New England Journal of Medicine, 380(1), 11-22.
- Burdge, G. C. & Calder, P. C. (2005). Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reproduction Nutrition Development, 45(5), 581-597.
- EFSA Panel on Dietetic Products, Nutrition and Allergies (2010). Scientific opinion on the substantiation of health claims related to EPA, DHA and ALA. EFSA Journal, 8(10), 1796.
- Estruch, R., Ros, E., Salas-Salvado, J., et al. (2013). Primary prevention of cardiovascular disease with a Mediterranean diet. New England Journal of Medicine, 368(14), 1279-1290.
- Grosso, G., Pajak, A., Marventano, S., et al. (2014). Role of omega-3 fatty acids in the treatment of depressive disorders. PLoS ONE, 9(5), e96905.
- Innis, S. M. (2007). Dietary (n-3) fatty acids and brain development. Journal of Nutrition, 137(4), 855-859.
- Larmo, P. S., Yang, B., Hyssala, J., et al. (2014). Effects of sea buckthorn oil intake on vaginal atrophy in postmenopausal women. Maturitas, 79(3), 316-321.
- Lawson, L. D. & Hughes, B. G. (1988). Absorption of eicosapentaenoic acid and docosahexaenoic acid from fish oil triacylglycerols or fish oil ethyl esters co-ingested with a high-fat meal. Biochemical and Biophysical Research Communications, 156(2), 960-963.
- Manson, J. E., Cook, N. R., Lee, I. M., et al. (2019). Marine n-3 fatty acids and prevention of cardiovascular disease and cancer. New England Journal of Medicine, 380(1), 23-32.
- Serhan, C. N. (2014). Pro-resolving lipid mediators are leads for resolution physiology. Nature, 510(7503), 92-101.
- Simopoulos, A. P. (2002). The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomedicine & Pharmacotherapy, 56(8), 365-379.
- Zurier, R. B., Rossetti, R. G., Jacobson, E. W., et al. (1996). Gamma-linolenic acid treatment of rheumatoid arthritis. Arthritis & Rheumatism, 39(11), 1808-1817.
See also:



